Fortress Biotech receives FDA approval for Zycubo to treat Menkes disease
Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.
Drug Development
JPM26: SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody
Atara receives FDA complete response letter for Ebvallo BLA application
MediLink and Roche announce exclusive licensing agreement for YL201
Takeda and Halozyme sign global agreement for Enhanze technology
Santhera grants Agamree rights to Nxera for DMD
Octapharma receives FDA approval for new Fibryga formulation in AFD
Day One concludes Mersana Therapeutics acquisition
